This week we come to meta-analyse, strikingly late, the cornerstone of all CKD treatments. Are you still in doubt? We need ACEing CKD to the end of GFR, and beyond
This week, we will discuss hopefully the final story of intensive BP lowering. BPROAD is a larger version of ACCORD without the glycemic control arm. Dive in.
Its that time of year again! Jade Teakell is leading team #UrineItToWinIt for #HCWvsHunger 2024. Read more.
This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythmia.
Fascinating observational study on hyponatraemia correction rates this week, catch-up here.
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) November 17, 2023
✳️10 tweet #NephJC catch-up ✳️
The challenge has been declared to the concept that rate of hyponatraemia correction is as vital as nephrologists have been telling you - to know if you agree, you need to know the studies the challenge is based upon🧵👇 pic.twitter.com/S5XVH9QqRb
Check out the beautiful Visual Abstract for this week’s NephJC by Arjun Mohan.
